Race Oncology: Appoints Damian Clarke-Bruce as CEO and MD

Race Oncology Appoints Damian Clarke-Bruce as CEO and MD

• Race Oncology (RAC) appoints Damian Clarke-Bruce as Managing Director and Chief Executive Officer, effective from February 1, 2023
• The role comes with a $475,000 yearly salary and a short-term incentive of up to 40 per cent of this base salary
• As a result of the appointment, current CEO Phil Lynch will return to his position as a non-executive director of Race, after volunteering to step into the CEO in September 2020
• The pair will work closely to ensure a smooth and effective leadership transition
• RaceOncology shares are trading at $2.18 at 12:23 pm AEDT